JUNS

JUPITER NEUROSCIENCES INC

JUNS·48208B203·US·Common Stock·Healthcare - Biotechnology

JUNS (JUPITER NEUROSCIENCES INC) is held by 7 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($135,327), GEODE CAPITAL MANAGEMENT, LLC ($79,639), CITADEL ADVISORS LLC ($38,245). Net institutional sentiment: Mixed.

7
Holders
Avg rating(2 Elite)
$297,237
Total Value
55% (12)
Fund Consensus
6 buying - 5 selling

No verdict yet — fewer than 2 funds hold JUNS.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
359,911$135,3270.0%-59.57%
34
Increased
211,696(+59.6%)$79,6390.0%-84.24%
21
New
101,661$38,2450.0%-59.57%
31
New
87,789$33,0090.0%-59.57%
30
Unchanged
25,346$9,5350.0%-89.36%
0
New
3,928$1,4770.0%-59.57%
17
New
13,575$50.0%-59.57%
15
Exited
0(-100.0%)$14,7460.0%-72.31%
0
Exited
0(-100.0%)$1450.0%-72.25%
0
Exited
0(-100.0%)$21,9300.0%-70.36%
0
Exited
0(-100.0%)$3,0600.0%-56.48%
0
Exited
0(-100.0%)$29,8590.0%-56.48%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used